Abbott India Ltd 500488
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹29,188.60
- Day Range
- ₹29,071.40–29,480.00
- 52-Week Range
- ₹21,907.45–30,499.90
- Bid/Ask
- ₹0.00 / ₹0.00
- Market Cap
- ₹621.70 Bil
- Volume/Avg
- 700 / 643
Key Statistics
- Price/Earnings (Normalized)
- 49.77
- Price/Sales
- 10.47
- Dividend Yield (Trailing)
- 1.40%
- Dividend Yield (Forward)
- 1.40%
- Total Yield
- 1.40%
Company Profile
Abbott India Ltd is a drug manufacturing company that offers products in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. Its patient focus centers overwhelmingly on women's health and gastrointestine, gastroenterology, and hepatic care. Geographically, the majority of the company's revenue is generated in India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Large Growth
- Total Number of Employees
- 3,878
- Website
- https://www.abbott.co.in
Comparables
Valuation
|
Metric
|
500488
|
532815
|
543434
|
|---|---|---|---|
Price/Earnings (Normalized) | 49.77 | 52.55 | 34.56 |
Price/Book Value | 16.95 | 5.91 | 5.81 |
Price/Sales | 10.47 | 4.08 | 8.09 |
Price/Cash Flow | 57.26 | 36.20 | 36.48 |
Price/Earnings
500488
532815
543434
Financial Strength
|
Metric
|
500488
|
532815
|
543434
|
|---|---|---|---|
Quick Ratio | 1.91 | 0.86 | 2.47 |
Current Ratio | 2.42 | 1.61 | 5.17 |
Interest Coverage | 122.46 | 4.55 | 51.09 |
Quick Ratio
500488
532815
543434
Profitability
|
Metric
|
500488
|
532815
|
543434
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
500488
532815
543434
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| Brjjzygvg | Zncf | $790.4 Bil | |||
| Johnson & Johnson
JNJ
| Sgtdjfcmq | Jhmc | $388.5 Bil | |||
| AbbVie Inc
ABBV
| Yhccxwwk | Lrxlk | $344.1 Bil | |||
| Merck & Co Inc
MRK
| Vtqllgc | Wlznz | $288.2 Bil | |||
| Roche Holding AG ADR
RHHBY
| Bvdjhttn | Xjmmc | $258.7 Bil | |||
| AstraZeneca PLC ADR
AZN
| Dwldjrjtf | Wbxt | $242.3 Bil | |||
| Novartis AG ADR
NVS
| Grxfyfnz | Ncfgh | $234.2 Bil | |||
| Amgen Inc
AMGN
| Wxkbmrqnc | Rln | $173.4 Bil | |||
| Pfizer Inc
PFE
| Sspfnxfc | Mhs | $164.8 Bil | |||
| Sanofi SA ADR
SNY
| Klgnnvgy | Ngpmd | $144.3 Bil |
United States